Breaking News

Bioserv Appoints Pharma Technologies SVP

April 21, 2014

Schrier brings 25 years of analytical and development experience

Jay Schrier, Ph.D., has been appointed senior vice president of Pharmaceutical Technologies at Bioserv Corp.

Dr. Schrier has more than 25 years of analytical and pharmaceutical development experience and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharma industry. Prior to joining the company, he was senior director of pharmaceutical development at Pacira Pharmaceuticals.

Al Hansen, chairman and chief executive officer of Bioserv Corp. and managing partner at KESA Partners, said, “We are excited to welcome someone with Dr. Schrier’s outstanding qualifications and leadership skills to our growing executive team at Bioserv. His development expertise will result in significant value creation for our manufacturing clients. Dr. Schrier will provide expertise to our clients to enable them to manufacture their products to high quality standards but in a cost-effective manner.”

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.